Reactions Weekly

, Volume 1658, Issue 1, pp 373–373 | Cite as

Pembrolizumab

Myasthenia gravis: case report
Case report
  • 29 Downloads

Reference

  1. Baten A, et al. AntiPD1 antibody pembrolizumab treatment of metastatic thymic cancer as antigenic trigger for myasthenia gravis. Neurology 88 (Poster Abstr.): P2 141, No. 16, 18 Apr 2017 [abstract] - USAGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations